Close MenuClose
Close Menu
Robert John Anderson, MD

Professor

Robert Anderson

Contact

School of Medicine
Department of Medicine
Endocrinology
Fellowship - endocrinology

Robert John Anderson, MD

Professor

Department

Medicine

Position

Professor

Books

  • Yousefian, S. Anderson, R.J. Cushing’s disease identified post-adrenalectomy for adrenal nodules. In “The Art of Neuroendocrinology: A Case-Based Approach to Medical Decision-Making" Editor Blevins, L.S., Nova Science Publishers (www.novapublishers.com), (ISBN:978-1-53610-917-7), Chapter 17, pp. 161-173, April, 2017. 2017

Articles

  • BMJ
    , Leehey, D, Carlson K, Reda DJ, Craig I, Clise C, Conner TA, Agarwal R, Kaufman JS, Anderson, RJ, Lammie D, Huminik J, Polziin L, McBurney C, Huang GD, Emanuele NV. Pentoxifylline in Diabetic Kidney Disease (VA PTXRx): protocol for a pragmatic randomized controlled trial. BMJ Open 2021 Aug 16;11(8):e053019. 2021
  • N Engl J Med
    , Heerspink, H.J.L., Stefanson, B.V., Correa-Rotter, R., et al. for the DAPA-CKD Trial Committes and Investigators (includes R.J. Anderson as Site PI). Dapagliflozin in Patients with Chronic Kidney Disease. N. Engl. J. Med. 383:1436-46, 2020; DOI: 10.1056/NEJMoa2024816 2020
  • JAMA Internal Medicine
    Rosenstock, J., Perkovic, V., Johansen, O.E., et al. for the CARMELINA Investigators (includes R.J. Anderson as Site PI). Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk: The CARMELINA Randomized Clinical Trial. JAMA.doi:10.1001/jama.2018.18269. Published online November 9, 2018. Corrected November 29, 2018.  2019
  • Diabetes Care
    *Zhou, J.J., Schenke, D.C., Bahn, G. et al. for the VADT Investigators (includes R.J. Anderson): Glycemic Variation and Cardiovascular Risk in the Veterans Affairs Diabetes Trial. Diabetes Care 41:2187-2194, 2018
    41, p. 2187-2194 2019
  • The Lancet
    Gerstein, H.C., Colhoun, H.M., Dagenais, G.R., et al. for the REWIND Investigators (includes R.J. Anderson as Site PI). Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomized, placebo-controlled trial. The Lancet Published online June 10, 2019; https://doi.org/10.1016/S0140-6736(19)31150-X 2019
  • Davis S.N., Duckworth, W., Emanuele, N., Hayward, R.A., Wiitala, W.L., Thottapurathu, L., Reda, D.J., Reaven, P.D. for the Investigators of the VADT (includes R.J. Anderson): Effects of severe hypoglycemia on cardiovascular outcomes and death in the Veterans Affairs Diabetes Trial. Diabetes Care 2019;42:157-163 \ https://doi.org/10.2337/dc18-1144 
    42, p. 157-63 2019
  • *Reaven PD, Emanuele NV, Wiitala WL, et al. for the Investigators of the VADT (includes R.J. Anderson) Intensive Glucose Control in Patients with Type 2 Diabetes -15-Year Follow-up. N Engl J Med. 2019; 380(23):2215-2224. http://dx.doi.org/10.1056/NEJMoa1806802 
    380;23, p. 2215-2224 2019
  • Endocrine Practice
    Drincic, A.,  Nguyen, A-T, Singh, S., Zena, M., Walters, R., Friedman, K., Anderson, R.J.: Pituitary Evaluation in Patients with Low Prostate Specific Antigen (PSA). Endocrine Practice 24:1030-1037, 12 December 2018. 
    24, p. 1030-37 2018
  • N Engl J Med
    Wiviott, S.D., Raz, I., Bonaca, M.P., et al. for the DECLARE-TIMI 58 Investigators (includes R.J. Anderson as Site PI). Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes. N. Engl. J. Med. DOI: 10.1056/NEJMoa1812389. Published November 19, 2018 2018
  • Endocrine Practice
    Drincic A, Nguyen AT, Singh S, Zena M, Walters R, Friedman K, Anderson RJ. PITUITARY EVALUATION IN PATIENTS WITH LOW PROSTATE SPECIFIC ANTIGEN.   [Epub ahead of print] PubMed PMID: 30289304.
    doi: 10.4158/EP-2018-0204 2018
  • Diabetologia
    Agrawal, L., Azad, N., Bahn, G.D. et al. for the VADT Study Group (includes R.J.Anderson as Site PI): Long-term follow-up of intensive glycemic control on renal outcomes in the Veterans Affairs Diabetes Trial (VADT). Diabetologia 61:295-299, 2018
    61, p. 295-299 2018
  • AACE Clinical Case Report
    Mark Henry Joven and Robert J. Anderson (2016) Pneumocystis jirovecii Pneumonia Associated with Systemic Glucocorticoids in the Treatment of Type 2 Amiodarone-Induced Thyrotoxicosis. AACE Clinical Case Reports: Winter 2016, Vol. 2, No. 1, pp. e46-e49.
    2016, Vol. 2, No. 1, p. e46-e49 2016
  • Consultant 360
    Joven, M., Anderson, R.J.:White Knight. Consultant 360. In Press, August 2015
    2015 55(8), p. 666-668 2015
  • Endocrine Pathology
    Shah, K, Zena, M, Adickes, E, and Anderson, RJ: Case of concurrent MTC and PTC in a patient with a germline RET mutation. Endocrine Pathology. In Press July 10, 2015.
    2015 (26), p. 279-283 2015
  • Current Diabetes Reports
    Joven MH, Anderson RJ. Update on blood pressure control and renal outcomes in diabetes mellitus. Curr Diab Rep. 2015 Jul;15(7):613. doi: 10.1007/s11892-015-0613-6. PMID: 25990743
    2015 Jul;15(7), p. 613 2015
  • New England Journal of Medicine
    Hayward, R., Reaven, P., Wiitala, W., Bahn, G., Reda, R., Ge, L., McCarren, M., Duckworth, W., and Emanuele, N., for the VADT Investigators (includes Anderson, RJ, Site Principal Investigator). Follow-up of Glycemic Control and Cardiovascular Outcomes in Type 2 Diabetes. New England Journal of Medicine. 2015 June;372(23):2197-2206. doi: 10.1056/NEJMoa1414266.
    2015 June;372(23), p. 2197-2206 2015
  • Diabetes Care
    Leiter L, Teah H, Braunwald E, et al. for the SVAOR-TIMI 53 Steering Committee and Investigators (includes Anderson, RJ as Site PI). Efficacy and safety of Saxigliptin in older participants in the SAVOR-TIMI 53 Trial. Diabetes Care 2015;1145-1153 / DOI: 10.2337/dc14-2868.
    2015 June 38(6), p. 1145-1153 2015
  • Metabolism
    Saremi A, Schwenke DC, Bahn G, Ge L, Emanuele N, Reaven PD; VADT Investigators (includes R.J. Anderson as site PI). The effect of intensive glucose lowering therapy among major racial/ethnic groups in the Veterans Affairs Diabetes Trial (VADT). Metabolism . 2015 Feb;64(2):218-25. doi: 10.1016/j.metabol.2014.10.010. Epub 2014 Oct 17.
    2015 Feb;64(2), p. 218-25 2015
  • AACE Clinical Case Report
    Joven, M.H., Hutfless, G.S., Anderson, R.J.: Follicular Thyroid Cancer with Pulmonary Metastasis Presenting as Toxic Autonomously Functioning Thyroid Nodule. AACE Clinical Case Reports vol 1:e1-e4, DOI:10.4158/EP14384.CR, January, 2015.
    Vol 1, p. e1-e4 2015
  • BMJ Case Report
    Shah, K.K., Tarasova, V.D., Davidian, M., Anderson, R.J.: Painful Acute Radiation Thyroiditis Induced By 131I Treatment of Graves’ Disease. BMJ Case Reports. [Published online 1/9/2015] doi:10.1136/bcr-2014-207670 (PMID: 25576511)., p. OnLine 2015
  • Endocrine Practice
    Tarasova, V.D., Nahar, N.N., Dietz, N., Recker, R.R., Anderson, R.J.: Unique Occurrence and Course in a Patient with PTEN Hamartoma Tumor Syndrome and Graves’ Disease. Letters to the Editor, Endocr Pract 20 (No.12) 1-2, December, 2014.
    Vol. 20, No. 12, p. 1354-1356 2014
  • Endocrine
    Joven M.H. and Anderson, R.J.: Marine-Lenhart Syndrome Endocrine 2014, September; DOI 10.1007/s12020-014-0412-x (PMID: 25205447).
    2015 Jun;49(2), p. 570-1 2014
  • Diabetes Care
    Anderson, R.J., Bahn, G., Emanuele, N. Marks, J., Duckworth, W. for the VADT Study Group. Blood pressure and pulse pressure effects on renal outcomes in the Veterans Affairs Diabetes Trial (VADT). Diabetes Care. 2014. http://care.diabetesjournals.org/content/early/2014/07/16/dc14-0284. Published online July 21, 2014. Diabetes Care 37:2782-2788, 2014. (PMID: 25048382).
    July 21, 2014, p. OnLine 2014
  • American College of Endocrinology Self Assessment Program
    Drincic, A. and Anderson, R.J.: Adrenal Hirsutism/Virilization, Adrenal Section for the American College of Endocrinology Self Assessment Program (ASAP-online) 2014. Available at: https://education.aace.com., p. OnLine 2014
  • Diabetologia
    Azad N, Agrawal L, Emanuele NV, Klein R, Bahn GD, Reaven P; VADT Study Group (includes R.J. Anderson as site PI). Association of Blood Glucose Control and Pancreatic Reserve with Diabetic Retinopathy in Veterans Affairs Diabetes Trial (VADT). Diabetologia. 2014 Jun;57(6):1124-31. doi: 10.1007/s00125-014-3199-7. Epub 2014 Mar 6
    2014 Jun;57(6):1124-31, p. 218-25 2014
  • Journal of Diabetes and Its Complications
    Jenkins, A.J., Fu, D., Azar, M., Stoner, J.A., Kaufman, D.G., Zhang, S.X., Klein, R.L., Lopes-Virella, M.F., Ma, J.X.& Lyons, T.J.and the VADT Study Group (includes R.J. Anderson as site PI) Clinical Correlates of Serum Pigment Epithelium-Derived Factor in Type 2 Diabetes Patients. J Diabetes Complications. 2014 May-Jun;28(3):353-9. doi: 10.1016/j.jdiacomp.2014.01.008. Epub 2014 Jan 17.
    2014 May-Jun;28(3), p. 353-9 2014
  • BMJ Case Report
    Shah, K., Anderson, R.J.: Adrenal insufficiency as the presenting manifestation of small cell lung carcinoma metastatic to the infundibulum and pituitary. BMJ Case Reports 2014; doi:10.1136/bcr-2013-203224 (PMID#24532238).
    2014 Feb 14;2014 2014
  • Diabetes Care
    Azad N, Agrawal L, Emanuele NV, Klein R, Bahn GD, McCarren M, Reaven P, Hayward R, Duckworth W and the VADT Study Group (includes R.J. Anderson as site PI). Association of PAI-1 and Fibrinogen with Diabetic Retinopathy in the Veterans Affairs Diabetes Trial (VADT) Diabetes Care, 2014 Feb; 37 (2) 501-6.
    2014 Feb; 37 (2) , p. 501-6 2014
  • Front. Endocrinol.
    Mark B Zimering, Robert J Anderson, Ling Ge, Thomas E Moritz, William C Duckworth, for the VADT Study Investigators (includes R.J. Anderson as site PI). Basic fibroblast growth factor predicts cardiovascular disease occurrence in participants from the Veterans Affairs Diabetes Trial. Front Endocrinol, 2013 Nov 22. doi: 10.3389/fendo.2013.00183. (PMID: 24319441)
    2013 Nov 22;4, p. 183 2013
  • New England Journal of Medicine
    Fried, L.F., Emanuele, N., Zhang, J.H. et al. for the VA NEPHRON-D Investigators (includes R.J. Anderson, M.D.), Combined angiotensin inhibition for the treatment of diabetic nephropathy. N. Engl. J. Med. November 9, 2013. DOi:10.1056/NEJMoa1303154.
    November 9, 2013, p. 1892-903 2013
  • New England Journal of Medicine
    Scirica,B.M., Bhatt, D.L., Braunwald, E, et al. and the SAVOR-TIMI 53 Investigators (includes R.J. Anderson as site PI) Saxagliptin and cardiovascularoutcomes in patients with Type 2 diabetes mellitus. N. Engl. J. Med. 2013. DOi:10.1056/NEJMoa1307684.
    2013 Oct 3;369(14), p. 1317-26 2013
  • Diabetes Care
    Koska J, Saremi A, Bahn G, Yamashita S, Reaven PD for the VADT Investigators (includes R.J. Anderson as site PI). The Effect of IntensiveGlucose Lowering on Lipoprotein Particle Profiles and Inflammatory Markers in the Veterans Affairs Diabetes Trial (VADT). Diabetes Care. 2013 published ahead of print March 27, 2013, doi:10.2337/dc12-2082.
    2013 Aug;36(8), p. 2408-14 2013
  • Journal of Diabetes and Its Complications
    Madona Azar, Timothy J. Lyons, Petar Alaupovic, Julie A. Stoner, Carmen Quiroga, Derrick G. Kaufman, Maria Lopes-Virella, Richard L. Klein, Alicia J. Jenkins, VADT Study Group (includes R.J. Anderson as site PI). Apolipoprotein-defined and NMR lipoprotein subclasses in the veterans affairs diabetes trial. J Diabetes Complications. 2013 Aug 1. doi:pii: S1056-8727(13)00113-X. 10.1016/j.jdiacomp.2013.05.005. [Epub ahead of print]
    2013 Nov-Dec;27(6), p. 627-32 2013
  • Front. Endocrinol.
    Mark B. Zimering, Thomas E. Moritz, Robert J. Donnelly for the VADT Study Group (includes R.J. Anderson as site PI). Anti-Neurotrophic Effects from Autoantibodies in Adult Diabetes Having Primary Open Angle Glaucoma or Dementia. Front Endocrinol (Lausanne). 2013; 4: 58.
    2013; 4, p. 58 2013
  • Diabetes
    Zinman, B., Kahn, S.E., Haffner, S.M., O’Neill, M.C., Heise, M.A., Freed, M.I. for the ADOPT Study Group (includes R.J.Anderson): Phenotypic characteristics of GAD antibody-positive recently diagnosed patients with Type 2 diabetes in North America and Europe.
    53, p. 3193-3200 2004
  • J. Clin Endo. and Metab.
    Ebmeier, C.C. and Anderson, R.J.: Human thyroid phenol sulfotransferases SULT1A1 and SULT1A3: Activities in normal and diseased thyroid glands, and inhibition by thyroid hormones and phytoestrogens.
    89, p. 5597-5605 2004
  • 12 International Congress of Endocrinology Proceedings, Lisbon, Portugal
    Anderson, R. and Ebmeier, C.: Human anterior pituitary sulfotransferase SULT1A1 and SULT1A3 activities. , p. 1197-1201 2004
  • 12 International Congress of Endocrinology Proceedings, Lisbon, Portugal
    Shah, J., Kirkman, S., Wendel, C., McCarren, M., Duckworth, W., Abraira, C. and the VADT group (includes R.J. Anderson). Baseline Macrovascular Disease Correlates in Older Type 2 Diabetic Patients in US Veterans Affairs Diabetes Trial (VADT). , p. 653-658 2004
  • 12 International Congress of Endocrinology Proceedings, Lisbon, Portugal
    Abraira, C., Sacks, J., Emanuele, N., Klein, R., Duckworth,W., and the VADT Group (includes R.J. Anderson). Retinopathy Associations in the V.A. Diabetes Trial. , p. 435-439 2004
  • Diabetes Care
    Reaven, P.D., Sacks, J. and VADT investigators (includes R.J. Anderson). Reduced Coronary and abdominal Artery Calcification in Hispanics with type 2 Diabetes.
    27, p. 1115-1120 2004
  • ASAP (AACE Self Assessment Profile in Endocrinology and Metabolism) Syllabus
    Anderson, R.J.: Adrenal Hirsutism/Virilization, Adrenal Section
    2003-2004, p. In Press 2004
  • Current Medical Research and Opinion
    McKenney, J.M., Jones, P.H., Adamczyk, M.A., Cain, V.A., Bryzinski, B.S., Blasetto, J.W. for the STELLAR Study Group (includes R.J. Anderson): Comparison of the efficacy of rosuvastatin versus atorvastatin, simvastatin, and pravastatin in achieving lipid goals: results from the STELLAR trial.
    19, p. 689-698 2003
  • Journal of Diabetes and Its Complications
    Abraira, C., Duckworth, W., McCarren, M., Emanuele, N., Arca, D., Reda, D., Henderson, W. for the participants of the VA Cooperative Study of Glycemic Control and Complications in Diabetes Mellitus Type 2 (includes RJ Anderson): Design of the Cooperative Study on Glycemic Control and Complications in Diabetes Mellitus Type 2: Veterans Affairs Diabetes Trial (VADT).
    17, p. 314-322 2003
  • American Journal of Cardiology
    Jones, P.H., Davidson, M.H., Stein, E.A. et al, for the STELLAR Study Group (includes R.J. Anderson): Comparison of the efficiacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR Trial).
    92, p. 152-160 2003
  • Not Applicable
    Anderson, R.J.: Adrenal Hirsutism/Virilization, Adrenal Section for the ASAP (AACE Self Assessment Profile in Endocrinology and Metabolism) 2003-4 Syllabus
    In Press 2003
  • Biochem. Biophys. Res. Commun.
    Ibert C. Wells, John P. Classen, and Robert J. Anderson; A test for adequacy of chromium nutrition in humans-relation to Type 2 diabetes ,ellitus.
    303, p. 825-827 2003
  • J. Diabetes and Its Complications
    Abraira, C., Duckworth, W., McCarren, M., Emanuele, N., Arca, D., Reda, D., Henderson, W. for the participants of the VA Cooperative Study of Glycemic Control and Complications in Diabetes Mellitus Type 2 (includes RJ Anderson): Design of the Cooperative Study on Glycemic Control and Complications in Diabetes Mellitus Type 2: Veterans Affairs Diabetes Trial (VADT).
    In Press 2003
  • American Journal of Cardiology
    Freed, M.I., Ratner, R., Marcovina, S.M., Kreider, M.M., Biswas, N., Cohen, B., Brunzell, J.D. and the Rosiglitazone Study 108 Investigators (includes R.J. Anderson): Effects of Rosiglitazone alone and in combination with atorvastatin on the metabolic abnormalities in type 2 diabetes mellitus.
    90, p. 947-952 2002
  • Journal of Clinical Endocrinology and Metabolism
    Hartman, M.L., Crowe, B.J, Biller, B.M.K., Ho, K.Y., Clemmons, D.R., Chipman, J.J. and The HypoCCS Advisory Board and The U.S. HypoCCS Study Group (includes R.J. Anderson): Which patients do not require a GH stimulation test for the diagnosis of adult GH deficiency?
    87, p. 477-485 2002
  • J. Endocrinol.
    Li, X-Y, Clemens, D.L., Cole, J.R. and Anderson, R.J.: Characterization of human liver thermostable phenol sulfotransferase (SULT1A1) allozymes with 3,3',5-triiodothyronine as the substrate.
    171(#3), p. 525-532 2001
  • New England Journal of Medicine
    Lewis, E.J., Hunsicker, L.G., Clarke, W.C., Berl, T., Pohl, M.A., Lewis, J.B., Ritz, E., Atkins, R.C., Rohde, R., and Raz, I. for the Collaborative Study Group (includes R.J. Anderson): Renoprotective effect of the angiotensin-receptor anatgonist irbesartan in patients with nephropathy due to Type 2 diabetes.
    345, p. 851-860 2001
  • J Clin Endocrinol Metab
    Lebovitz HE, Dole JF, Patwardhan R, Rappaport EB, Freed MI for the Rosiglitazone Clinical Trials Group (includes RJ Anderson). Rosiglitazone monotherapy is effective in patients with Type 2 diabetes.
    86:, p. 280-288 2001
  • ASAP (AACE Self Assessment Profile in Endocrinology and Metabolism) Syllabus
    Anderson RJ: Adrenal hirsutism/virilization, Adrenal Section of the 2000 Syllabus., p. 17-25 2001
  • Bone
    Dubin RL, Hall CM, Pileri CL, Kudlacek PE, Yee JA, Li X-Y, Johnson ML, Anderson RJ. Thermostable (SULTIA1) and thermolabile (SULTIA3) phenol sulfotransfereases in human osteosarcoma and osteoblast cells.
    28:, p. 617-624 2001
  • Diabetes Care
    Rosenstock J,Schwartz SL, Clark CM, Park GD, Conley DW, Edwards MN (for the 3006 Study Group, including RJ Anderson). Basal insulin therapy in Type 2 diabetes: 28-week comparison of insulin glargine (HOE 901) and NPH insulin.
    24:, p. 631-636 2001
  • Nephrol Dial Transplant
    Rodby RA, Rohde RD, Clarke WR, Hunsicker LG, Anzalone DA, Lewis EJ for the Collaborative Study Group (includes RJ Anderson). The irbesartan type II diabetic nephropathy trail: Study design and baseline characteristics.
    15:, p. 487-497 2000
  • J Am Soc Nephrol
    White KE and Bilous RW for the Collaborative Study Group IDNT (Includes RJ Anderson). Type 2 diabetic patients with nephropathy show structural-functional relationships that are similar to Type 1 diabetes.
    11:, p. 1667-1673 2000
  • Biochem Pharmacol
    Li X, Clemens DL, Anderson RJ: Sulfation of iodothyronines by recombinant human sulfotransferase SULTICI.
    60:, p. 1713-1716 2000
  • Not Applicable
    Thrailkill, K.M., Quattrin, T., Baker, L., Kuntze, J.E., Compton, P.G., Martha, P..M. for the rhIGF-I in IDDM Study Group (includes R. J. Anderson): Cotherapy with recombinant human insulin-like growth factor-I and insulin improves glycemic control in Type 1 diabetes Diabetes Care 22: 585-592, 1999 1999
  • Not Applicable
    Patel, J., Anderson, R.J., Rappaport, E.B.: Rosiglitazone monotherapy improves glycemic control in patients with type 2 diabetes: A 12-week, randomized placebo-controlled study. Diabetes, Obesity & Metabolism, 1:165-172, 1999 1999
  • Not Applicable
    Li, Xinying and Anderson, R.J.: Sulfation of iodothyronines by recombinant human liver steroid sulfotransferases. Biochem. Biophys. Res. Comm. 263:632-639, 1999. 1999
  • Not Applicable
    4.Anderson, R.J.: ”Hypopituitarism.” In: Conn's Current Therapy, 2000, Ed, R.E. Rakel, pp. 635-640, Philadelphia, W.B. Saunders Company, 2000. 1999
  • JAMA Internal Medicine
    Rosenstock, J., Perkovic, V., Johansen, O.E., et al. for the CARMELINA Investigators (includes R.J. Anderson as Site PI). Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk: The CARMELINA Randomized Clinical Trial. JAMA.doi:10.1001/jama.2018.18269. Published online November 9, 2018. Corrected November 29, 2018
  • Wells, I.C., Claassen, J.P. and Anderson, R.J.: A test for adequacy of chromium nutrition in humans- Relation to Type 2 diabetes mellitus. Submitted, Biochem. Biophys. Res. Comm., 2002.
  • Wells, I.C.and Anderson, R.J.: Involvement of magnesium in the etiology of Type 2 diabetes mellitus. Submitted to Diabetes, 2002.
  • Diabetologia
    Agrawal, L., Azad, N., Bahn, G.D. et al. for the VADT Study Group (includes R.J.Anderson as Site PI): Long-term follow-up of intensive glycemic control on renal outcomes in the Veterans Affairs Diabetes Trial (VADT). Diabetologia 61:295-299, 2018
    61, p. 295-299

Publications

  • A Case Report
    , Shanthakumari P Jinnur, MD 1 , Robert J Anderson, MD , MS 2, Ashley M. Bauer, MD 3 , Omar S. Akbik, MD 4 Giant Growth Hormone (GH)-Secreting Pituitary Tumor with Massive Sphenoid Sinus Invasion and Spontaneous Cerebrospinal Fluid (CSF) Leak: A Case Report. Submitted to ENDO2022. 2022
  • Journal of the Endocrine Society
    , Reddy, C., Zena, M., Gallagher, J.C., Recker, R.R., and Anderson, R.J.: Bilateral Atypical Femoral Fracture (AFF) after teriparatide and subsequent anti-resorptive therapy: a management dilemma. ENDO2021:Abstract #6896, Poster Session P10, March 20, 2021. Journal of the Endocrine Society, Volume 5, Issue Supplement_1, April-May 2021, Page A184, https://doi.org/10.1210/jendso/bvab048.372 2021
  • Journal of the Endocrine Society
    , Albrecht, J., Ahmed, M., Nandala, S., Farooqi, S. Anderson, R.J.: Postpartum Thyroid Abnormalities and Systemic Lupus Erythematosus: Is There a Link? ENDO2021:Abstract #4324, Poster Session P49, March 20, 2021. Journal of the Endocrine Society, Volume 5, Issue Supplement_1, April-May 2021. Pages A948-A949 https://doi.org/10.1210/jendso/bvab048.1938 2021
  • ACP Nebraska Chapter
    , Jordan Albrecht, Moeed Ahmed MBBS, Sudha Nandala MBBS, Saad Farooqi MBBS and Robert Anderson MD. Postpartum Thyroid Abnormalities and Systemic Lupus Erythematosus: Is There a Link? ACP Nebraska Chapter Abstract Presentations, October 10, 2020, Omaha, NE. 2020
  • Journal of the Endocrine Society
    , Nagireddi, R.P., Win, H.H., Wagstaff, S., Neal, M., Friedman, K., Anderson, R.J.:Adrenal reserve testing with the Glucagon Stimulation Test (GST) and Cosyntropin Stimulation Test (CST) in deployed Veterans with mild Traumatic Brain Injury. SUN-311 (ENDO2020 Meeting March 28-31 Canceled). Journal of the Endocrine Society, Volume 4, Issue Supplement_1, April-May 2020. (PMC7208304) https://doi.org/10.1210/jendso/bvaa046.604 2020
  • Endocrine Practice
    Nagireddi, R., Anderson, R.; CONGENITAL ADRENAL HYPERPLASIA WITH TESTICULAR ADRENAL REST TUMORS AND BILATERAL ADRENAL MYELOLIPOMAS: A TREATMENT DILEMMA. 2019 AACE ANNUAL SCIENTIFIC & CLINICAL CONGRESS ABSTRACTS. Endocrine Practice: April 2019, Vol. 25, (Supplement 1), pp. 16-17. https://doi.org/10.4158/1934-2403-25.s1.1 
    25, p. 16-17 2019
  • Endocrine Practice
    Lin, W.W. and Anderson, R.J.;  OCTREOTIDE LONG-ACTING RELEASE (OCT-LAR) USE IN PREGNANCY: IS IT CONSIDERED SAFE? 2019 AACE ANNUAL SCIENTIFIC & CLINICAL CONGRESS ABSTRACTS. Endocrine Practice: April 2019, Vol. 25, (Supplement 1), p.250. https://doi.org/10.4158/1934-2403-25.s1.1. 
    25, p. 250 2019
  • Win, H.H., Anderson, R.J.: HYPOGLYCEMIA DUE TO A "CONCEPTION-ENHANCING" ORAL SUPPLEMENT. AACE 27th Annual Meeting, Abstract Syllabus (Abst #307), Boston, MA. Endocrine Practice Vol 24 (Suppl 1): April, 2018. 2018
  • Lin, W., George, A., Anderson, R.: A Case of Hypocalciuric Hypercalcemia with A Rare Variant of CaSR Gene Mutation.  Presented at ENDO2018 Endocrine Society Annual Meeting, Chicago IL. March 18, 2018. Endocrine Reviews 39 (Issue 2,Suppl), SUN-432: April, 2018. 2018
  • Addasi, N., George, A., `Recker, R., Anderson, R.: Clinical Features of Two Patients With Rebound Associated Vertebral Fractures After Denosumab.  Presented at ENDO2018 Endocrine Society Annual Meeting, Chicago IL. March 18, 2018. Endocrine Reviews 39 (Issue 2,Suppl), SAT-459: April, 2018. 2018
  • George, A., Anderson, R.J. and Yousefian, S.: A Rare Cause of Refractory Graves’ Disease. 87th Annual Meeting of the American Thyroid Association, Meeting Abstracts Syllabus, October 18-22, 2017; Victoria, BC, Canada. Poster 54, page 170.  THYROID Vol 27, Issue S1, Oct 2017; 1Oct2017 2017
  • George, A., Anderson, R.J.: MEN2A without Medullary Thyroid Cancer (MTC): A rare event or a misnomer? 87th Annual Meeting of the American Thyroid Association, Meeting Abstracts Syllabus, October 18-22, 2017; Victoria, BC, Canada. Poster 55, page 170.  THYROID Vol 27, Issue S1, Oct 2017; 1Oct2017 2017
  • Singh, S. and Anderson, R.J. EXTREMELY AGGRESSIVE PAPILLARY THYROID CANCER (PTC) WITH SPLENIC AND WIDESPREAD METASTASES, AND CLEAR CELL RENAL CELL CARCINOMA (RCC): AN UNKNOWN SYNDROMIC ENTITY OR POTENTIAL MANIFESTATION OF FAMILIAL PTC? Endocrine Practice Vol 23 (Suppl 3):210, 2017. Presented May 4, 2017 AACE 26th Annual Meeting (Abst #1001), Austin, TX. 2017
  • Singh, S. Nguyen, A-T, and Anderson, R.J. AN UNUSUAL CASE OF CONCOMITANT HYPERALDOSTERONISM AND HYPERCORTISOLISM IN A PATIENT WITH ADRENAL INCIDENTALOMA. Endocrine Practice Vol 23 (Suppl 3):6, 2017. Presented May 4, 2017 AACE 26th Annual Meeting (Abst #110), Austin, TX. 2017
  • George, A. and Anderson, R.J. INCREASED RISK OF THYROID CANCER IN PATIENTS WITH MULTINODULAR GRAVES’ DISEASE: SHOULD THYROIDECTOMY BE CONSIDERED THE TREATMENT OF CHOICE? Endocrine Practice Vol 23 (Suppl 3):229, 2017. Presented May 4, 2017 AACE 26th Annual Meeting (Abst #1034), Austin, TX. Selected as an e-poster as a top-scoring abstract. 2017
  • Nguyen, A-T, Singh, S., Drincic, A., Walters, R., Friedman, K., Zena, M., Anderson, R.J.:2Pituitary Evaluation in Patients with Low Prostate Specific Antigen (PSA): A Case-Control Study. Presented at ENDO2017 Endocrine Society Annual Meeting, Orlando, FL, April, 2017. 2017
  • Nguyen, AT., Kolukula, S., Colanta, A., and Anderson, R.J.: Unilateral Graves' Disease in a Bilateral Multinodular Goiter: Long-term Management and Complications. 86th Annual Meeting of the American Thyroid Association Meeting Abstracts, September 21-25, 2016; Denver CO. Poster 144, page 186.  DOI: 10.1089/thy.2016.29022.abstracts. 2016
  • Shah KK, Tarasova V, Anderson RJ:.A Case of a Functioning Extra-Adrenal Retroperitoneal Composite Paraganglioma and Ganglioneuroma. Endocrine Practice 22 (Supplement 1):24, 2016 (May). Presented May 27, 2016 AACE 25th Annual Meeting (Abst #142), Orlando, FL,.
    Abst #142 2016
  • Nguyen, A-T, Khanal, N., Lambrecht, J.E., Anderson, R.J.: Refractory Hypothyroidism Due to L-Thyroxine Malabsorption. Endocrine Practice 22 (Supplement 1):301, 2016 (May). Presented May 27, 2016 AACE 25th Annual Meeting (Abst #1196), Orlando, FL.
    Abst #1196 2016
  • Yousefian, S., Anderson, R.J.: Cushing's Disease Identified Post-Adrenalectomy for Adrenal Nodules. Endocrine Practice 22 (Supplement 1):215, 2016 (May). Presented May 27, 2016 AACE 25th Annual Meeting (Abst #939), Orlando, FL.
    Abst #939 2016
  • Endocrine
    Tarasova V.D., Shah K.K, White, M., Anderson, R.J, Armas, L.G.A.: Physiological Response of Cortisol to Cardiac Catheterization. Accepted for presentation at the ENDO2015, SAT-400, March 7, 2015. 2015
  • Endocrine
    Saiprasad, S., Gallagher, J.C., Anderson, R.J.: Chronic Functional Hypoparathyroidism due to Magnesium Deficiency. Accepted for presentation at the ENDO2015, SAT-203, March 7, 2015. 2015
  • Endocrine
    Shah, K.K., Joven, M., Tarasova, V., Saiprasad, S., Flor, S., Anderson, R.J. Anterior pituitary dysfunction in military Veterans with mild Traumatic Brain Injury (mTBI): A pilot study. Accepted for presentation at the 14th International Pituitary Congress. March 3-4, 2015 2015
  • Endocrine
    Shah, K.K., Tarasova, V.D., Davidian, M., Anderson, R.J.: Painful acute radiation thyroiditis induced by 131I treatment of Graves’ disease. ICE/ENDO2014, SAT- 0523, June 21, 2014. 2014
  • Endocrine
    Shah, K.K., Anderson, R.J.: Therapeutic benefits of growth hormone replacement therapy in growth hormone deficient patients following traumatic brain injury: a systematic review. ICE/ENDO2014, SAT-0731, June 21, 2014. 2014
  • Endocrine
    Joven, M., Anderson, R.J.: Follicular thyroid cancer presenting as a hot nodule and subclinical hyperthyroidism. ICE/ENDO2014, SAT-0493, June 21, 2014. 2014
  • Other
    Tarasova, V.D., Nahar, N., Dietz, N.E., Recker, R.R., Anderson, R.J.: Unique Occurrence and Course of Graves’ Disease in a Patient with PTEN Hamartoma Tumor Syndrome. THYROID 23.No.S1,A-66 (Poster #150). American Thyroid Association 83rd Ann Meeting, San Juan Puerto Rico, October 16-20, 2013, 2013
  • Other
    Tarasova, V.D., Kolukula, S., Anderson, R.J.: A novel mutation of thyroid hormone receptor Beta subunit causing resistance to thyroid hormone. THYROID 23.No.S1,A-76 (Poster #177).American Thyroid Association 83rd Ann Meeting, San Juan Puerto Rico, October 16-20, 2013. 2013
  • Diabetes
    Anderson, R.J., Bahn, G., Emanuele, N. Marks, J., Duckworth, W.: Blood pressure and pulse pressure effects on renal outcomes in the Veterans Affairs Diabetes Trial (VADT). Diabetes 62:Supplement 1; Late Breaking Abstracts:2013-LB-5755-Diabetes, July 2013.
    2014 Oct;37(10), p. 2782-8 2013
  • ENDO2005, Endocrine Society Mtg
    Olin, J.R., Ebmeier, C.C., Anderson, R.J.: Human premenopausal and postmenopausal liver steroid sulfotransferase (SULT) activities with tibolone metabolites. , p. (P2-304) 430 2005
  • ENDO2005, Endocrine Society Mtg
    Ebmeier, C.C., Olin, J.R., Anderson, R.J.: Sulfation of tibolone metabolites by postmenopausal human liver produces predominantly monosulfated compounds. , p. P2-305) 430 2005
  • Diabetes
    Emanuele, N., Sacks, J., Klein, R., Duckworth W, Abraira C., and the Veterans Affairs Diabetes Trial (VADT) group (includes RJ Anderson). Ethnicity and other retinopathy correlations of baseline photographs in the VA Diabetes Trial. New Orleans, LA.
    53 2004
  • Diabetes
    Kirkman, M.S., McCarren, M., , Abraira C., Duckworth W., and the VADT study group (includes R.J. Anderson). Cardiovascular disease correlates with traditional risk factors but not with glycemic control in established Type 2 diabetes. New Orleans, LA
    53:S2, p. A77 2004
  • Not Applicable
    Zimering, M.B., Sacks, J. and the VADT study group (includes R.J. Anderson). Plasma basic fibroblast growth factor (bFGF) increases with degree of abdominal obesity in patients with Ytype 2 diabetes mellitus enrolled in the Veterans Affairs Diabetes Trial (VADT). Boston, MA
    In Press 2004
  • FASEB Journal
    Wang, M. and Anderson, R.J.: Sulfation of tibolone metabolites by postmenopausal human liver sulfotransferase activities. 2004 Experimental Biology meeting abstracts [on CD-ROM].
    18, p. 646.9 2004
  • FASEB Journal
    Ebmeier, C. and Anderson, R.J.: Phytoestrogen sulfation by human thyroid phenol sulfotransferases (SULTs): Inhibition of the SULT activities by daidzein and genistein. 2004 Experimental Biology meeting abstracts [on CD-ROM].
    18, p. 793.9 2004
  • Diabetes and Metabolism
    Abraira C, Duckworth W, McCarren M, Shah J, Anderson R and the Veterans Affairs Diabetes Trial (VADT) group. Cardiovascular (CV) risk factors in the Veterans Affairs Diabetes Trial (VADT).
    29 (4S), p. 341 2003
  • Diabetes and Metabolism
    Anderson R, Duckworth W, Abraira C, McCarren M, Shah J and the Veterans Affairs Diabetes Trial (VADT) group. Design and baseline characteristics of the VADT: The effects of glucose control on cardiovascular outcomes in Type 2 diabetes.
    29 (4S), p. 341 2003
  • Not Applicable
    Abraira, C., Duckworth, W.C., McCarren, M., Shah,J., Anderson, R.J., and the VADT Investigators: Cardiovascular (CV) risk factors in the Veterans Affairs Diabetes Trial (VADT). 18th IDF Congress, In Press, 2003. 2003
  • Not Applicable
    Herman, W., Freed, M.I., Heise, M., Kravitz, B., Perry, A., and the ADOPT Study Group (includes R.J. Anderson): The ADOPT Study: symptoms and health status in a recently-diagnosed type 2 diabetic population(Abs.#1130). In Press 63rd Scientific Sessions of the ADA, New Orleans, LA, June 13-17, 2003. 2003
  • Not Applicable
    Haffner, S.M., Zinman, B., Kahn, S.E., Herman, W.H., Heise, M.A., O’Neill, M.C., Porter, L.E., and the ADOPT Study Group (includes R.J. Anderson): Ethnic differences in the prevalence of the metabolic syndrome in recently diagnosed type 2 diabetes in North America (Abs.#945). 63rd Scientific Sessions of the ADA, New Orleans, LA, June 13-17, 2003. 2003
  • Not Applicable
    Kahn, S.E., Haffner, S.M., Zinman, B., Heise, M.A., O’Neill, M.C., Porter, L.E., and the ADOPT Study Group (includes R.J. Anderson): Lack of concordance of NCEP and WHO criteria for the diagnosis of the metabolic syndrome in recently diagnosed diabetes in North America and Europe (Abs.#952). 63rd Scientific Sessions of the ADA, New Orleans, LA, June 13-17, 2003. 2003
  • Not Applicable
    Zinman, B., Kahn, S.E., Haffner, S.M., Herman, W.H., Heise, M.A., O’Neill, M.C., and the ADOPT Study Group (includes R.J. Anderson): Prevalence and clinical significance of glutamic acid decarboxylase (GAD) antibodies in recently diagnosed type 2 diabetes: The ADOPT Study Cohort (Abs.#999). 63rd Scientific Sessions of the ADA, New Orleans, LA, June 13-17, 2003. 2003
  • Not Applicable
    Viberti, G.C., Freed, M.I., Holman, R., Lachin, J., Heise, M., and the ADOPT Study Group (includes R.J. Anderson): Prevalence of microalbuminuria and its relationship to non-traditional risk factors in recently diagnosed type 2 diabetes mellitus: observations from the ADOPT Study (Abs.#817). 63rd Scientific Sessions of the ADA, New Orleans, LA, June 13-17, 2003. 2003
  • Not Applicable
    Anderson, R.J., Duckworth, W.C., Abraira, C., McCarren, M., Shah,J., and the VADT Investigators: Design and baseline characteristics of the Veterans Affairs Diabetes Trial (VADT): the effect of glucose control on cardiovascular (CV) outcomes in Type 2 diabetes. 18th IDF Congress, In Press, 2003. 2003
  • Not Applicable
    Anderson, R.J., Abraira, C., Duckworth, W.C., McCarren, M., Zimering, M.B., and the VADT Trial Group: Blood pressure control in the Veterans Affairs Diabetes Trial (VADT). The Endocrine Society 85th Annual Meeting, In Press, 2003. 2003
  • Not Applicable
    Ebmeier, C.C., Anderson, R.J.: Human Thyroid Phenol Sulfotransferases (SULT1A1 and SULT1A3): Biochemcial Properties and Activities in Normal and Diseased Thyroids. The Endocrine Society 85th Annual Meeting, In Press, 2003. 2003
  • Not Applicable
    Middleton, J.P., Lewis, J., for the Collaborative Study Group – IDNT Study (includes RJ Anderson): Predictors of the progression of renal insufficiency in patients with type 2 diabetes and overt diabetic nephropathy. American Society of Nephrology Annual Scientific Meeting 2002
  • Not Applicable
    Atkins, R., Braden, G., Briganti, E., de Crespigny, P.J.C., DeFerrari, G., Drury, P., Hunsicker, L., Lewis, J., Locatelli, F., Wiegmann, T.B. for the Collaborative Study Group (includes RJ Anderson): Effect of baseline proteinuria and change in proteinuria on risk of renal endpoints in the IDNT. American Society of Nephrology Annual Scientific Meeting, November 1-5, 2002 2002
  • Not Applicable
    Rodby, R. Gilbert, R. for the Collaborative Study Group – IDNT Study (includes RJ Anderson): The presence of retinopathy is associated with poor renal and cardiovascular outcomes type 2 diabetic nephropathy. American Society of Nephrology Annual Scientific Meeting, November 1-5, 2002. 2002
  • Not Applicable
    Pohl, M.A., Cordonnier, D.J., Spitalewitz, S. and the Collaborative Study Group – IDNT Study (includes RJ Anderson): Impact of angiotensin receptor blockade with irbesartan on renal function at different systolic blood pressure (SBP) levels in type 2 diabetic nephropathy. American Society of Nephrology Annual Scientific Meeting, November 1-5, 2002. 2002
  • Not Applicable
    Weir, M.R., Hunsicker, L.G. for the Collaborative Study Group – IDNT Study (includes RJ Anderson): The severity of orthostatic hypotension is a risk factor in the progression of type 2 diabetic nephropathy. American Society of Nephrology Annual Scientific Meeting, November 1-5, 2002. 2002
  • Not Applicable
    Pohl, M.A., Blumenthal, S., Hunsicker, L.G. and the Collaborative Study Group – IDNT Study (includes RJ Anderson): Impact of achieved systolic blood pressure on the renal function in type 2 diabetic nephropathy. American Society of Nephrology Annual Scientific Meeting, November 1-5, 2002. 2002
  • Not Applicable
    Berl, T., for the Collaborative Study Group (includes RJ Anderson): Cardiovascular outcomes in the irbesartan diabetic nephropathy trial (IDNT) of patients with type 2 diabetes and overt nephropathy. American Society of Nephrology Annual Scientific Meeting, November 1-5, 2002. 2002
  • Not Applicable
    Anderson, R.J., Kudlacek, P.E., Li, X-Y,: Thermostable phenol sulfotransferase (SULT1A1) is present in COS-1cells and catalyzes the sulfation of 3,3’-diiodothyronine. (28th Annual Meeting of the European Thyroid Association, Goteborg, Sweden, September 7-11, 2002); Journal of Endocrinological Investigation 25: (Suppl to No.7), 59, 2002. 2002
  • Not Applicable
    Hardin, K.N., Kudlacek, P.E., Li, X-Y, Anderson, R.J.: Thermostable phenol sulfotransferase (SULT1A1) is present in SV40 transformed African green monkey kidney cells (COS-1). Proceedings of the Southwestern and Rocky Mountain Division AAAS-SWARM, 3rd Annual Midwest Meeting (Omaha, NE, Nov. 11-13) 41 (#2):18, 2001. 2001
  • Not Applicable
    Li, X-Y, Clemens, D., Anderson, R.: Specificities of human hydroxysteroid sulfotransferase 2B1a (SULT2B1a) and mutant SULT2B1a enzymes for thyroid hormones and dehydroepiandrosterone (DHEA). Washington, D.C. 2001
  • Abstract Book
    Sype, J.W. and Anderson, R.J. : A case of long-standing hyponatremia and hypothyroidism associated with an incidentally discovered pituitary macroadenoma, October, 2001
    ACP-ASIM, Nebraska Chapter Meeting Proceedings,, p. In Press 2001
  • ENDO2001, Endocrine Society Mtg
    Abraira C, Duckworth W, McCarren M and the VADT Study Group (includes RJ Anderson): The Veterans Affairs Type 2 Diabetes Trial (VADT). Denver, CO 2001
  • Soc Mol Biol Genet
    Li-X-Y, Clemens DL, Anderson RJ: Alteration of human hydroxysteroid sulfotranferase 2B1a (SULT2B1a) substrate affinities by mutation of amino acid residues., Omaha, NE, p. #15 2001
  • American Society of Hypertension
    Lewis EJ, Hunsicker LG, Clarke WC for the Collaborative Study Group (includes RJ Anderson): A clinical trial in patients with overt type 2 diabetic nephropathy. 2001
  • ICE (International Congress of Endocriniology) 2000 Abstracts
    Anderson RJ, Li X-Y, Clemens D: Sulfation of thyroid hormones by multiple human recrombinant cytosolic sulfotransferases (SULTs), p. 277 2000
  • FASEB Journal
    Li X-Y, Anderson R: Human liver recombinant thermostablel phenol sulfotransferase (SULTIA1) allozymes characterized with iodothyronines.
    14:, p. A1446 2000
  • Not Applicable
    Kudlacek, P., Clemens, D., Anderson, R.: Human liver recombinant thermostable phenol sulfotransferase (SULT1A1) allozymes characterized with minoxidil. FASEB J. 13(#5):A1013, 1999 1999
  • Not Applicable
    Kudlacek, P., Clemens, D., Anderson, R.: Human liver recombinant thermostable phenol sulfotransferase (SULT1A1) allozymes characterized with minoxidil. J. Invest. Med. 47:197A, 1999 1999
  • Not Applicable
    Li, X.-Y. and Anderson, R.: Sulfation of triiodothyronine by recombinant human liver steroid sulfotransferases. FASEB J. 13(#5):A813, 1999 1999
  • Not Applicable
    Li, X.-Y. and Anderson, R.: Sulfation of triiodothyronine by recombinant human liver steroid sulfotransferases . J. Invest. Med. 47:199A, 1999 1999
  • Not Applicable
    Hartman, M., Crowe, B., Chipman, J., for the HypoCCS Investigator Group (includes R.J. Anderson): Baseline characteristics of adults with GH deficiency (GHD): comparison of patients who receive GH replacement therapy with those not treated. Program of the 6th International Pituitary Congress, p.61, Long Beach, CA, June 15-17, 1999 1999
  • Not Applicable
    Rosenstock, J., Schwartz, S., Clark, C., Edwards, M., Donley, D. (Protocol 3006 Study Group includes R. Anderson): Efficacy and safety of HOE901 (insulin glargine) in subjects with type 2 DM: a 28-week randomized, NPH insulin-controlled trial. Diabetes 48: (Suppl. 1):A100, 1999 1999
  • Not Applicable
    Kudlacek, P., Anderson, R.: Altered biochemical properties of recombinant human liver chimeric sulfotransferases (SULT). Proceedings of the Southwestern and Rocky Mountain Division AAAS, 1st Midwest Regional Meeting (Omaha, NE, October 31- November 2) 39 (#2):24, 1999 1999
  • Not Applicable
    Li, X.-Y., Clemens, D., Anderson, R.: Thyroid hormone sulfation by recombinant human sulfotransferase SULT1C1. Proceedings of the Southwestern and Rocky Mountain Division AAAS, 1st Midwest Regional Meeting (Omaha, NE, October 31- November 2) 39 (#2):25, 1999. 1999
  • ENDO2022
    , Shanthakumari P Jinnur, MD 1 , Robert J Anderson, MD , MS 2, Ashley M. Bauer, MD 3 , Omar S. Akbik, MD 4 Giant Growth Hormone (GH)-Secreting Pituitary Tumor with Massive Sphenoid Sinus Invasion and Spontaneous Cerebrospinal Fluid (CSF) Leak: A Case Report. Submitted to ENDO2022. -0001
  • Endocrine Practice
    Kunwar, S., Nagireddi, R., Zena, M., Anderson, R.; AUTOIMMUNE THYROID DISEASE: HYPOTHYROIDISM CONVERSION TO HYPERTHYROIDISM. 2019 AACE ANNUAL SCIENTIFIC & CLINICAL CONGRESS ABSTRACTS. Endocrine Practice: April 2019, Vol. 25, (Supplement 1), pp. 292-3. https://doi.org/10.4158/1934-2403-25.s1.1 
    25, p. 292-3

Presentations

  • Thyroid Nodules and Ultrasound. Anderson, R. Creighton University Endocrinology Grand Rounds, Omaha, NE. 2019
  • Inpatient Management of DM. Anderson, R., George, A. Creighton University Department of Medicnie Grand Rounds, Omaha, NE. 2019
  • Hyperthyroidism: Uncommon Presentations and Treatments Challenges. Anderson, R. Creighton University Endocrinology Grand Rounds, Omaha, NE. 2019
  • Autoimmune thyroid disease: Hypothyroidism conversion to Hyperthyroidism. Kunwar, S., Nagireddi, R., Anderson, R., Zena, M. AACE 2019, Los Angeles, CA. 2019
  • Octreotide Long-Acting Release (OCT-LAR) Use in Pregnancy: Is It Considered Safe? Lin, W., Anderson, R. AACE 2019, Los Angeles, CA. 2019
  • Congenital Adrenal Hyperplasia with Testicular Adrenal Rest Tumors and Bilateral Adrenal Myelolipomas: A Treatment Dilemma. Nagireddi, R., Anderson, R. AACE 2019, Los Angeles, CA. 2019
  • Growth Hormone Deficiency (GHD) over 4 years after mild traumatic Brain Injury in deployed veterans. Lin, W., Anderson, R. Endocrine Society 2019, New Orleans, LA.  2019
  • Faculty Speaker, “Traumatic Brain Injury and Endocrine Dysfunction in Veterans,” Creighton Department of Medicine Grand Rounds, Omaha, NE, December 16, 2015. 2015
  • Speaker, “Thyroid Nodules' Medicine Resident Core Series, Department of Medicine, Division of Endocrinology, Omaha, NE, October 23, 2015 2015
  • Speaker, “Thyroid Update' Endocrine Fellowship Core Series, Department of Medicine, Division of Endocrinology, Omaha, NE, July 7, 2015 2015
  • Speaker, “Mild Traumatic Brain Injury and Pituitary Dysfunction: Update,” Creighton Department of Medicine Research Conference, Omaha, NE, May 14, 2015 2015
  • Speaker, “Pheochromocytoma,” Endocrine Fellowship Core Series, Department of Medicine, Division of Endocrinology, Omaha, NE, May 12, 2015. 2015
  • Speaker, Pituitary Board Reviews, Internal Medicine Board Review Lectures, CUMC, May 11, 2015. 2015
  • Faculty Moderator “Adrenal 2,” Department of Medicine Reisdent Core Lectures, April 6, 2015. 2015
  • Faculty Moderator “Adrenal 1,” Department of Medicine Resident Core Lectures, March 30, 2015. 2015
  • Faculty Moderator “Thyroid,” Department of Medicine Reisdent Core Lectures, March 23, 2015. 2015
  • M2 Introduction to Clinical Medicine (1 hour), “Adrenal,” CUSM, January 27, 2015. 2015
  • M2 Introduction to Clinical Medicine (1 hour), “Hypothalamic-Pituitary Function and Disease,” CUSM, January 26, 2015. 2015
  • Speaker, “Cushing’s Update' Endocrine Fellowship Core Series, Department of Medicine, Division of Endocrinology, Omaha, NE, January 20, 2015. 2015
  • Board Reviews; Endocrine Fellows, November 25, 2014. 2014
  • Speaker, “Mild Traumatic Brain Injury and Pituitary Dysfunction,” Creighton Department of Medicine Research Conference, Omaha, NE, October 9, 2014. 2014
  • Speaker, “Cushing’s' Endocrine Fellowship Core Series, Department of Medicine, Division of Endocrinology, Omaha, NE, September 16, 2014. 2014
  • Speaker, “Thyroid Physiology' Endocrine Fellowship Core Series, Department of Medicine, Division of Endocrinology, Omaha, NE, July 22, 2014,. 2014
  • Invited speaker, “Endocrine Emergencies,” Acute Care Core Curriculum Series, Department of Medicine, Omaha, NE, July 2, 2014. 2014
  • Speaker, “Genetic screening and counseling in endocrine metabolic diseases,” Endocrine Fellowship Core Series, Department of Medicine, Division of Endocrinology, Omaha, NE, July 1, 2014. 2014
  • Speaker, Thyroid Board Reviews, Internal Medicine Board Review Lectures, CUMC, June 2, 2014. 2014
  • Speaker, “Acromegaly' Endocrine Fellowship Core Series, Department of Medicine, Division of Endocrinology, Omaha, NE, May 27, 2014. 2014
  • Speaker, “Pheochromocytoma,” Endocrine Fellowship Core Series, Department of Medicine, Division of Endocrinology, Omaha, NE, February 18, 2014. 2014
  • Invited Speaker, DKA and HHS Treatment Approaches with Insulin Infusion,” Pulmonary and Critical Medicine Conference, CUMC, Omaha, NE, February 7, 2014. 2014
  • M2 Introduction to Clinical Medicine (1 hour), “Adrenal,” CUSM, January 28, 2014. 2014
  • M2 Introduction to Clinical Medicine (1 hour), “Hypothalamic-Pituitary Function and Disease,” CUSM, January 27, 2014. 2014
  • Speaker, “VA-NEPHRON-D: End of combination therapy for diabetic Nephropathy?” Department of Medicine Grand Rounds, CUMC, December 18, 2013. 2013
  • Speaker, 'Thyroid Ultrasound and FNA Applications.' Endocrine Fellowship Core Series, Department of Medicine, Division of Endocrinology, Omaha, NE, December 17, 2013. 2013
  • Invited Speaker, “Veterans Affairs Diabetes Trial (VADT) and Renal Outcomes,” Research Conference, Department of Medicine, Omaha, NE, November 14, 2013. 2013
  • Speaker, “Diabetic Emergencies: DKA and HHS,” Endocrine Fellowship Core Series, Department of Medicine, Division of Endocrinology, Omaha, NE, November 12, 2013. 2013
  • Speaker, “Mild Traumatic Brain Injury and Pituitary Dysfunction,” Creighton Osteoporosis Research Center Friday Conference, Omaha, NE, November 8, 2013. 2013
  • Speaker, “Cushing’s' Endocrine Fellowship Core Series, Department of Medicine, Division of Endocrinology, Omaha, NE, September 24, 2013. 2013
  • Invited speaker, “Endocrine Emergencies,” Acute Care Core Curriculum Series, Department of Medicine, Omaha, NE, August 8, 2013. 2013
  • Speaker, “Hypothyroidism Update,” Endocrine Fellowship Core Series, Department of Medicine, Division of Endocrinology, Omaha, NE, July 30, 2013 2013
  • Guest Speaker, Metabolism of tibolone metabolites in human tissues, Advisory Meeting, San Diego, CA 2005
  • Invited speaker, “Internal Medicine Board Reviews-Endocrinology (1.5 hours),” 2005
  • Invited Speaker, “Antithyroid Drugs,” Morning Report, Department of Medicine, VAMC 2005
  • Guest Speaker (Funded), “Sulfation of Tibolone Metabolites by Human Postmenopausal Tissues,” Tibolone Metabolism Symposium, Philadelphia, PA, March 31, 2005. 2005
  • Invited Speaker, “Hypogonadism,” Morning Report, Department of Medicine, VAMC 2005
  • Invited Speaker, “Thyroid Nodules,” Morning Report, Department of Medicine, VAMC 2005
  • Invited Speaker, “Initiation of Insulin in Diabetes Mellitus,” Morning Report, Department of Medicine, VAMC 2004
  • Invited Speaker, “Subclinical Thyroid Disease,” Morning Report, Department of Medicine, VAMC 2004
  • Invited speaker, “Endocrine Emergencies,” Acute Care Core Curriculum Series, Department of Medicine, Omaha, NE, 2004
  • Invited Speaker (Funded), “Metabolic Syndrome,” Council Bluffs, IA, June 17, 2004. 2004
  • Oral Presentation-Ebmeier, C. and Anderson, R.J.: Phytoestrogen sulfation by human thyroid phenol sulfotransferases (SULTs): Inhibition of the SULT activities by daidzein and genistein. EB(Experimental Biology)2004 International Meeting, Washington, DC 2004
  • Wang, M. and Anderson, R.J.: Sulfation of tibolone metabolites by postmenopausal human liver sulfotransferase activities. EB (Experimental Biology) Poster Presentation 2004
  • 'Maintaining HbA1c Separation in the Long-term VADT Study.' VA Diabetes Trial (VADT) COOP Study #465 Investigators’ Meeting, Chicago, IL 2004
  • Invited speaker, “Nazi Doctors” Grand Rounds, Omaha, NE, March 24, 2004. 2004
  • Invited speaker, Treatment of Thyroid Diseases, Family Practice Lecture Series, Omaha, NE 2004
  • Invited Speaker, “Treatment Strategies in the VA Diabetes Trial,” VA Staff Physician Conference, Lincoln VAMC, Lincoln, NE 2003
  • Invited Speaker (Funded), “Diabetic Dyslipidemia: Treatment Update,” Marshalltown Iowa Medical Staff Meeting 2003
  • Invited speaker, “Endocrine Emergencies,” Acute Care Core Curriculum Series, Department of Medicine, Omaha, NE 2003
  • Guest Symposium Speaker, “Blood pressure control in the VA Diabetes Trial (VADT),” Clinical Trials Symposium, Endocrine Society 2003, Philadelphia, PA 2003
  • Blood pressure control in the Veterans Affairs Diabetes Trial (VADT) 2003
  • Thyroid Hormone Metabolism:reSULTs and inSULTs. Creighton University Department of Medicine Research Conference 2003
  • Speaker, 'Hormones for Aging Men: HRT Deja Vu?' Creighton University School of Medicine Grand Rounds 2003
  • Invited Speaker, “Choosing Appropriate Patients for Weight Loss,” Morning Report, Department of Medicine, VAMC. 2003
  • Research in Type 2 Diabetes at the VA 2003
  • Invited Speaker, “Hyperglycemia in Acutely Ill Patients,” Morning Report, Department of Medicine, VAMC. 2002
  • Invited Speaker, “Subclinical Thyroid Disease,” Morning Report, Department of Medicine, VAMC. 2002
  • Invited Speaker amd Moderator (Funded), “Diabetes Treatment Programs:CADRE,” Ironwood Golf Club, Omaha Nebraska, November 2, 2002. 2002
  • Invited Speaker (Funded), “Managing Methods and Strategies for ATP III Goal Attainment: Conquering the New Treatment Frontier,” Nick and Tony’s, Omaha, Nebraska. 2002
  • Invited Speaker, “Drugs for treatment of Diabetes- An Update,” Nursing Inservice, Ambulatory Care, VAMC, October 18, 2002. 2002
  • Invited Speaker, “HDL Cholesterol as a risk factor,” Morning Report, Department of Medicine, VAMC, October 10, 2002. 2002
  • Invited speaker, “Hospital Control of Diabetes Mellitus- discussant panel,” Creighton University Department of Medicine Grand Rounds, Omaha, NE. 2002
  • Invited Speaker, “Prevention of Diabetes Mellitus,” Morning Report, Department of Medicine, VAMC. 2002
  • Invited Speaker, “Classification of Diabetes Mellitus,” Morning Report, Department of Medicine, VAMC. 2002
  • Invited Speaker (Funded), “Metabolic Syndrome: A Tale of the Tape-Treatment Options,” The French Café, Omaha Nebraska 2002
  • Department of Medicine, “Endocrine Board Review Session” 2 hours 2002
  • “Recent Classification of Diabetes Mellitus,” Morning Report, Department of Medicine, VAMC 2002
  • “Diabetic Nephropathy,” Morning Report, Department of Medicine, VAMC 2002
  • Department of Medicine Grand Rounds, “Some Endocrine Nutraceuticals: What are we to do?” 2002
  • “Hospital-Based Diabetes Treatment,” Morning Report, Department of Medicine, VAMC 2002
  • “Hypertension in Diabetes,” Morning Report, Department of Medicine, VAMC 2002
  • Invited speaker, 'Pituitary Apoplexy,' Department of Medicine Morning Report, Omaha, NE. 2002
  • Invited Speaker, 'Nodular Thyroid Disease,' Morning Report, Department of Medicine, VAMC. 2002
  • Invited Speaker (Funded), 'Optimizing Lipid Lowering: Utilizing the Most Recent Therapies in Getting Patients to Goal,' The French Café, Omaha Nebraska. 2002
  • Invited Speaker, 'Metabolic Syndrome,' Morning Report, Department of Medicine, VAMC. 2002
  • Invited Speaker, 'Adrenal insufficiency,' Morning Report, Department of Medicine, VAMC. 2001
  • Hardin, K.N., Kudlacek, P.E., Li, X-Y, Anderson, R.J.: Thermostable phenol sulfotransferase (SULT1A1) is present in SV40 transformed African green monkey kidney cells (COS-1). Proceedings of the Southwestern and Rocky Mountain Division AAAS-SWARM, 3rd Annual Midwest Meeting (Omaha, NE, Nov. 11-13) 41 (#2):18, 2001. 2001
  • Invited Speaker, 'Drugs that cause hyperglycemia,' Morning Report, Department of Medicine, VAMC. 2001
  • Invited Speaker, 'Diagnosis of Diabetes,' Morning Report, Department of Medicine, VAMC. 2001
  • Sype, J.W. and Anderson, R.J. : A case of long-standing hyponatremia and hypothyroidism associated with an incidentally discovered pituitary macroadenoma, ACP-ASIM, Nebraska Chapter Meeting Proceedings, 2001
  • Invited Speaker, 'Hyperthyroidism,' Morning Report, Department of Medicine, VAMC. 2001
  • Invited Speaker, 'Cholesterol Guideline Update,' Morning Report, Department of Medicine, VAMC. 2001
  • Invited speaker, 'Endocrine Emergencies,' Department of Medicine, Omaha, NE, 2001
  • Invited speaker, 'Thyrotoxicosis,' Department of Medicine Morning Report, Omaha, NE. 2001
  • 'ADA Recognized Diabetes Outpatient Program', VAMC, Omaha, NE 2001
  • 'VISN 14 Diabetes Guidelines', VAMC, Omaha, NE 2000
  • 'Hypopituitarism' University of Santo Tomas School of Medicine and Surgery, Manila, Philippines 2000
  • Anderson RJ, Li X-Y, Clemens D: Sulfation of thyroid hormones by multiple human recrombinant cytosolic sulfotransferases (SULTs). Presentation at the International Congress of Endocrinology, Sydney, Australia 2000
  • 'VISN 14 Diabetes Guidelines', VAMC, Omaha, NE 2000
  • 'Thyroid Disease in Primary Care, Family Practice Lecture Series, Omaha, NE 2000
  • 'Oral agent therapy in Type 2 diabetes', VAMC Nurse Inservice, Omaha, NE 2000
  • Kudlacek, P., Clemens, D., Anderson, R.: Human liver recombinant thermostable phenol sulfotransferase (SULT1A1) allozymes characterized with minoxidil. FASEB J. 13(#5):A1013, 1999 1999
  • Li, X.-Y. and Anderson, R.: Sulfation of triiodothyronine by recombinant human liver steroid sulfotransferases. FASEB J. 13(#5):A813, 1999. 1999
  • Kudlacek, P., Anderson, R.: Altered biochemical properties of recombinant human liver chimeric sulfotransferases (SULT). Proceedings of the Southwestern and Rocky Mountain Division AAAS, 1st Midwest Regional Meeting (Omaha, NE, October 31- November 2) 39 (#2):24, 1999 1999
  • Li, X.-Y., Clemens, D., Anderson, R.: Thyroid hormone sulfation by recombinant human sulfotransferase SULT1C1. Proceedings of the Southwestern and Rocky Mountain Division AAAS, 1st Midwest Regional Meeting (Omaha, NE, October 31- November 2) 39 (#2):25, 1999. 1999
  • Department of Medicine Grand Rounds, 'Adult Male Hypogonadism,' August 18, 1999. 1999
  • Invited (Funded) Commentator, 'Side Effects and adverse events with adult growth hormone therapy,' 3rd Annual International HypoCCS Meeting, Lido at Venice, Italy, April 17, 1999 1999
  • Invited (Funded) Speaker, Robert Bolinger Annual Lecture, 'Androgen replacement therapy for adult male hypogonadism: ART for ADAM,' UKMC Departments of Medicine and Endocrinology, Kansas City, Kansas, April 7, 1999 1999
  • Invited (Funded) Guest Lectureship, 'Male Hypogonadism Case Discussions,' Medical Education Dinner, UKMC Department of Endocrinology, Kansas City, MO, April 6, 1999 1999
  • Invited (Funded) Guest Lectureship, 'Androgen deficiency in the adult male: Diagnosis and Treatment,' Medical Education Conference, Good Samaritan Hospital/ Health Systems, Kearney, NE, March 12, 1999. 1999
  • Invited Lecturer, 'MEN Syndromes', UNMC Endocrinology Conference, UNMC and VA Medical Centers, Omaha, NE, January 12, 1999. 1999
  • Invited (Funded) Guest Lectureship, 'When and how to treat the androgen deficient adult male', Department of Medicine Grand Rounds, Rose Medical Center, University of Colorado Health Sciences Center, Denver, CO, January 5, 1999. 1999

Awards

  • Alpha Omega Alpha Honorary
    2017 Alpha Omega Alpha Honorary elected as Faculty.
  • Performance Award- Special Contribution to the Department of Veterans Affairs Mission
  • Visiting Professor of Endocrinology to University of Santo Tomas School of Medicine and Surgery, Manila, Philippines
  • VA Merit Review Award;